Introduction: The effect of radical cystectomy (RC) on cancer-specific mortality (CSM) is unclear in non-metastatic sarcomatoid bladder cancer (SBC) patients. We aimed to test the benefit of RC in SBC, and to perform a direct comparison vs urothelial bladder cancer (UCB). Materials and methods: Within the Surveillance, Epidemiology, and End...
-
2023 (v1)PublicationUploaded on: February 14, 2024
-
2022 (v1)Publication
Objective: To assess differences in the distribution of type and number of D'Amico high-risk criteria (DHRCs) according to race/ethnicity (R/E) and their effect on cancer-specific mortality (CSM) in prostate cancer (PCa) patients treated with external beam radiotherapy (RT). Methods: In the SEER database (2004–2016), we identified 31,002 PCa...
Uploaded on: February 6, 2024 -
2023 (v1)Publication
Introduction: The survival benefit of inguinal lymph node dissection (ILND) vs no ILND in patients with squamous cell carcinoma of the penis (SCCP) and the absence of lymph node invasion is unclear. We addressed this uncertainty within the Surveillance, Epidemiology and End Results (SEER 2000–2018) database. Material and methods: We identified...
Uploaded on: February 6, 2024 -
2022 (v1)Publication
Introduction The role of chemotherapy in metastatic sarcomatoid bladder cancer (mSBC) is un-known. The current work aimed to test the effect of chemotherapy on overall survival (OS) in mSBC patients. Material and methods Using the Surveillance, Epidemiology and End Results database (2001–2018), we identified 110 mSBC patients of all T and N...
Uploaded on: February 14, 2024 -
2022 (v1)Publication
Purpose: To investigate prevalence and predictors of renal function variation in a multicenter cohort treated with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC). Methods: Patients from 17 tertiary centers were included. Renal function variation was evaluated at postoperative day (POD)—1, 6 and 12 months....
Uploaded on: February 7, 2024